TITLE

Prevalence of and predictive factors for sustained diseasemodifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts

PUB. DATE
December 2009
SOURCE
International Journal of Advances in Rheumatology;2009, Vol. 7 Issue 4, p126
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This study of two cohorts of rheumatoid arthritis (RA) patients revealed that up to 15% of those who were treated with conventional therapy (disease-modifying anti-rheumatic drugs [DMARDs] or nonsteroidal antiinflammatory drugs) had sustained DMARD-free remission. Furthermore, this remission could be predicted by several factors.
ACCESSION #
48381920

 

Related Articles

  • Use of Liposomal Drugs in the Treatment of Rheumatoid Arthritis. Gulati, Monica; Singh, Saranjit; Chopra, Dimple; Duggal, Sanjiv; Kumar, Rajiv // Current Rheumatology Reviews;2008, Vol. 4 Issue 1, p63 

    Rheumatoid arthritis is an autoimmune disease that results in joint deformity and disability. Conventional nonsteroidal anti-inflammatory drugs (NSAIDs), steroids and disease modifying antirheumatic drugs (DMARD's) are used for its treatment. Unconventional therapies, like enzyme oligodeoxy...

  • News from EULAR.  // PharmacoEconomics & Outcomes News;7/25/2009, Issue 583, p7 

    The article discusses studies presented at the 10th Annual Congress of the European League Against Rheumatisim (EULAR). A study evaluated the costs and benefits of etanercept plus nonsteroidal anti-inflammatory drugs (NSAIDs) in patients with severe ankylosing spondylitis (AS). Research found...

  • Therapie der rheumatoiden Arthritis mit Methotrexat. Zeidler, J.; Zeidler, H.; Graf von der Schulenburg, J.-M. // Zeitschrift für Rheumatologie;Dec2012, Vol. 71 Issue 10, p900 

    Methotrexate (MTX) is the most important disease-modifying antirheumatic drug (DMARD) and is recommended by national and international guidelines as the first choice for treatment of rheumatoid arthritis (RA). Recent studies reporting prescription data of MTX captured only patients who were...

  • Rheumatoid arthritis among Nigerians: the first 200 patients from a rheumatology clinic. Adelowo, Olufemi; Ojo, Osaze; Oduenyi, Irene; Okwara, Chibuzo // Clinical Rheumatology;Jun2010, Vol. 29 Issue 6, p593 

    Rheumatoid arthritis has uncommonly been reported among Africans and rarely among West Africans. Most of the reported cases have been from Southern Africa. A recent awareness of increased reports of RA among Nigerians necessitated this study. The objective of this retrospective study was to...

  • Old disease new therapies. Daly, Mary; Falvey, Eanna // World of Irish Nursing & Midwifery;Jul/Aug2006, Vol. 14 Issue 7, p51 

    The article discusses on new therapies for the management of rheumatoid arthritis. The authors suggests that the first step in dealing with rheumatoid arthritis is to establish diagnosis in order to perform a baseline evaluation. They outline on the use of nonsteroidal anti-inflammatory drugs...

  • Evaluation of Small Bowel Injury in Patients with Rheumatoid Arthritis by Capsule Endoscopy: Effects of Anti-Rheumatoid Arthritis Drugs. Sugimori, Satoshi; Watanabe, Toshio; Tabuchi, Masahiko; Kameda, Natsuhiko; Machida, Hirohisa; Okazaki, Hirotoshi; Tanigawa, Tetsuya; Yamagami, Hirokazu; Shiba, Masatsugu; Watanabe, Kenji; Tominaga, Kazunari; Fujiwara, Yasuhiro; Oshitani, Nobuhide; Koike, Tatsuya; Higuchi, Kazuhide; Arakawa, Tetsuo // Digestion;2008, Vol. 78 Issue 4, p208 

    Background and Aim: The medical treatment of rheumatoid arthritis (RA) includes nonsteroidal anti-inflammatory drugs (NSAIDs), low-dose corticosteroids, and disease-modifying antirheumatic drugs (DMARDs). We evaluated the incidence of small bowel injury in RA patients who were taking anti-RA...

  • Medical Management of Children with Juvenile Rheumatoid Arthritis. Cassidy, J.T. // Drugs;Nov1999, Vol. 58 Issue 5, p831 

    One of the most important and changing areas of research in paediatric rheumatology is the optimum approach to the treatment of children with chronic arthritis. Until recently all medications for children with arthritis were nonspecific in terms of our understanding, albeit poor, of the...

  • Neue Kinasehemmer. Rubbert-Roth, A. // Zeitschrift für Rheumatologie;Aug2012, Vol. 71 Issue 6, p479 

    Treatment of rheumatoid arthritis (RA) has dramatically changed during the last 15 years. A limited number of conventional disease-modifying antirheumatic drugs (DMARD) in combination with non-steroid anti-inflammatory drugs (NSAID) and corticosteroids are facing a variety of biologics that are...

  • A total wrist arthroplasty in rheumatoid arthritis: a case followed for 24 years. Minami, Michio; Kato, Sadatoshi; Hirachi, Kazuhiko; Nagai, Masahiro // Modern Rheumatology (Springer Science & Business Media B.V.);Dec2004, Vol. 14 Issue 6, p488 

    We report a case of rheumatoid arthritis treated with a total wrist arthroplasty. A Meuli-type total wrist arthroplasty was performed on the left wrist in 1979. We have treated the patient’s rheumatoid arthritis with disease-modifying antirheumatic drugs (DMARDs) (Actarit 100?mg and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics